The impact of BMI on the course of the acute SARS-COV-2 infection and the risks that emerge during the first year after the hospital discharge. Subanalysis evidence of the AKTIV and AKTIV 2 registries
Authors:
- A G ArutyunovAAA G Arutyunov
- E I TarlovskayaETE I Tarlovskaya
- G R GalstyanGGG R Galstyan
- T I BatlukTBT I Batluk
- R A BashkinovRBR A Bashkinov
- G G ArutyunovGAG G Arutyunov
- Yu N BelenkovYBYu N Belenkov
- A O KonradiAKA O Konradi
- Yu M LopatinYLYu M Lopatin
- A P RebrovARA P Rebrov
- S N TereshchenkoSTS N Tereshchenko
- A I ChesnikovaACA I Chesnikova
Open Access
- 20 January 2023
- journal article
- research article
- Published by Endocrinology Research Centre in Problems of Endocrinology
- Vol. 68 (6) , 89-109
Abstract
BACKGROUND. There is enough evidence of the negative impact of excess weight on the formation and progression of res piratory pathology. Given the continuing SARS-CoV-2 pandemic, it is relevant to determine the relationship between body mass index (BMI) and the clinical features of the novel coronavirus infection (NCI).AIM. To study the effect of BMI on the course of the acute SARS-COV-2 infection and the post-covid period.MATERIALS AND METHODS. AKTIV and AKTIV 2 are multicenter non-interventional real-world registers. The АКТИВ registry (n=6396) includes non-overlapping outpatient and inpatient arms with 6 visits in each. The АКТИВ 2 registry (n=2968) collected the data of hospitalized patients and included 3 visits. All subjects were divided into 3 groups: not overweight (n=2139), overweight (n=2931) and obese (n=2666).RESULTS. A higher BMI was significantly associated with a more severe course of the infection in the form of acute kidney injury (p=0.018), cytokine storm (pCONCLUSION. Overweight and/or obesity is a significant risk factor for severe course of the new coronavirus infection and the associated cardiovascular and kidney damage Overweight people and patients with the 1st and 2nd degree obesity tend to have a high risk of death of SARS-CoV-2 infection in both acute and post-covid periods. On top of that, in case of morbid obesity patients this tendency is statistically significant. Normalization of body weight is a strategic objective of modern medicine and can contribute to prevention of respiratory conditions, severe course and complications of the new coronavirus infection.Keywords
This publication has 44 references indexed in Scilit:
- Arterial hypertension and risk of death in patients with COVID-19 infection: Systematic review and meta-analysisJournal of Infection, 2020
- High Prevalence of Obesity in Severe Acute Respiratory Syndrome Coronavirus‐2 (SARS‐CoV‐2) Requiring Invasive Mechanical VentilationObesity, 2020
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City AreaJAMA, 2020
- Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct PathophysiologyJournal of the American Society of Nephrology, 2020
- Obesity in Patients Younger Than 60 Years Is a Risk Factor for COVID-19 Hospital AdmissionClinical Infectious Diseases, 2020
- The effect of obesity on lung functionExpert Review of Respiratory Medicine, 2018
- Obesity and kidney disease: hidden consequences of the epidemicKidney International, 2017
- The dual roles of obesity in chronic kidney diseaseCurrent Opinion in Nephrology and Hypertension, 2016
- Body mass index and acute kidney injury in the acute respiratory distress syndromeCritical Care Medicine, 2012
- The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysisBMC Public Health, 2009